All authors have contributed to the experimental and analytical design. MWW, RPV, JFGV (thesis advisor) and GAV (thesis advisor) wrote the manuscript. All authors have read and approved the final manuscript.”
“Background Campylobacter jejuni is a major cause of food-borne gastroenteritis worldwide. In addition to causing disease in humans, this microorganism can colonize a variety of domestic animals, common and exotic pets, and domestic and wild birds; some of these alternate hosts experience disease [1, 2]. Successful experimental colonization of several mouse strains with C. jejuni has been
reported, but disease does not occur unless mice are immunodeficient selleck kinase inhibitor or wild type mice are experimentally manipulated [3]. Clinical presentation of campylobacteriosis in human patients in industrialized countries usually varies from mild watery diarrhea to severe bloody diarrhea; in developing countries, milder diarrhea and asymptomatic infections are also seen [1, 2]. YAP-TEAD Inhibitor 1 supplier Bacteremia can occur. Antecedent C. jejuni infection has been associated with the development of reactive arthritis and the autoimmune neuropathies Guillain Barré and Miller Fisher Syndromes. Disease expression in humans is likely the result of complex interactions between pathogen genetic properties, host genetic properties, host physiological state and immune response, and
the host intestinal microbiota [2, 4]. Environmental factors such as host diet may affect one or more of these factors; diet variables may act through mechanisms such as modulation of the host immune system by fatty acids or alteration of the composition of the complex microbial populations of the lower GI tract [5]. C. jejuni is a genetically variable
organism [6]. Over 3000 sequence types are cataloged in the Campylobacter jejuni Multi Locus Sequence Typing (MLST) database [7], and numerous studies employing other typing methods such as restriction fragment length polymorphisms (RFLP) in an array of genes, amplified fragment length polymorphisms, and microarray-based comparisons of entire genomes next have consistently revealed substantial genetic variation [8–13]. Furthermore, genetic variation has been documented in a number of virulence determinants, including genes involved in motility, iron metabolism, toxin synthesis and secretion, adherence to and invasion of eukaryotic cells, and capsule and lipo-oligosaccharide (LOS) synthesis [14–23]. Genetic variation affecting gene expression has been directly linked to in vivo variation in pathogenicity of two otherwise very similar strains from poultry [24]. C. jejuni also possesses mechanisms that could be expected to generate genetic diversity in vivo. MLST data, based on analysis of DNA sequences of genes for proteins of central metabolic pathways, have been used to deduce that recombination occurs in natural C. jejuni populations, both within C. jejuni and between C. jejuni and the closely related C.